TickerFacts.

Company research / MNOV

Medicinova Inc (MNOV)

Build a valuation ↗↓ Download CSV

SEC name MEDICINOVA INC · CIK 0001226616 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Medicinova Inc reported revenue of $409.7K. Over the twelve months to 2026-06-30, revenue was $920.5K.

Key ratios (year ended 2025-12-31)

n/m
Operating margin
n/m
Net margin
-28.9%
Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-29

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$920.5K$409.7Kn/a$1.00Mn/a$4.04Mn/an/an/an/an/a
R&D Expense$5.10M$6.70M$6.80M$5.30M$8.70M$8.10M$7.10M$5.70M$5.30M$3.90M$3.10M
Operating Income-$11.85M-$13.28M-$12.68M-$9.90M-$14.63M-$10.22M-$14.18M-$14.03M-$15.59M-$13.03M-$10.88M
Depreciation & Amortization$19.1K$20.1K$21.1K$20.3K$17.7K$26.1K$21.3K$23.9K$25.9K$28.1K$14.1K
EBITDA-$11.83M-$13.26M-$12.65M-$9.88M-$14.61M-$10.19M-$14.16M-$14.01M-$15.56M-$13.00M-$10.87M
Net Income-$10.75M-$12.00M-$11.05M-$8.57M-$14.07M-$10.13M-$13.85M-$12.94M-$14.68M-$11.16M-$10.87M
EPS (Diluted)n/a-$0.24-$0.23-$0.17-$0.29-$0.21n/an/an/an/an/a
Total Assets$40.43M$45.60M$55.88M$66.27M$74.15M$87.41M$75.42M$79.21M$77.22M$43.42M$39.81M
Total Liabilities$3.16M$4.02M$3.37M$3.89M$3.91M$3.73M$4.09M$4.31M$4.12M$4.78M$5.28M
Shareholders' Equity$37.27M$41.59M$52.50M$62.38M$70.24M$83.68M$71.33M$74.89M$73.11M$38.64M$34.53M
Cash & Equivalents$25.42M$30.81M$40.36M$51.00M$18.51M$71.43M$60.04M$63.79M$62.31M$27.99M$24.12M
Operating Cash Flow-$9.11M-$9.81M-$10.64M-$7.43M-$12.91M-$9.38M-$10.83M-$9.12M-$9.11M-$6.92M-$6.55M
Capital Expenditures$13.7K$2.9K$895$21.3K$5.0K$28.7K$36.5K$11.3K$10.2Kn/a$84.5K
Free Cash Flow-$9.12M-$9.81M-$10.64M-$7.45M-$12.92M-$9.41M-$10.86M-$9.14M-$9.12Mn/a-$6.63M
Shares Outstanding49.22M49.22M49.05M49.05M49.05M49.04M45.02M43.91M42.08M36.45M34.52M
Weighted Average Diluted Sharesn/a49.06M49.05M49.05M49.05M48.60Mn/an/an/an/an/a
EPS (Basic)n/a-$0.24-$0.23-$0.17-$0.29-$0.21n/an/an/an/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView